CHRISTINA MILLER: Open Payments
NPI 1215233507 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 50 payments from 12 companies in 2025. Trend: 2023 $1,443 · 2024 $1,072 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $172 |
| ABBVIE INC. | 11 | $160 |
| GENZYME CORPORATION | 4 | $84 |
| Aimmune Therapeutics, Inc. | 4 | $64 |
| Novo Nordisk Inc | 3 | $56 |
| QOL Medical, LLC | 2 | $40 |
| PFIZER INC. | 2 | $37 |
| Janssen Biotech, Inc. | 2 | $31 |
| Ardelyx, Inc. | 2 | $30 |
| Mannkind Corporation | 1 | $17 |
Products named: RELISTOR, LINZESS, DUPIXENT, ZENPEP, Sucraid, Wegovy, TREMFYA, IBSRELA.
Industry payments across AZ — which companies pay providers there.
